Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma.

Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma. Abstract Text:

Debra Kamstock,Robyn Elmslie,Douglas Thamm,Steven Dow,

Active immunization against pro-angiogenic growth factors or their receptors is an emerging strategy for controlling tumor growth and angiogenesis. Previous studies in rodent tumor models have indicated that immunization against xenogeneic growth factors is more likely to induce effective anti-tumor responses than immunization against the autologous growth factor. However, the effectiveness or safety of the xenogeneic vaccination approach has not been previously assessed in a clinically relevant outbred, spontaneous tumor model. Therefore, we investigated the safety and anti-tumor and anti-angiogenic effects of a xenogeneic vascular endothelial cell growth factor (VEGF) vaccine in pet dogs with spontaneous cancer. Nine dogs with soft tissue sarcoma were immunized with a recombinant human VEGF vaccine over a 16-week period. The effects of immunization on antibodies to human and canine VEGF, circulating VEGF concentrations, tumor microvessel density (MVD), and tumor growth were assessed. The xenogeneic VEGF vaccine was well-tolerated by all dogs and resulted in induction of humoral responses against both human and canine VEGF in animals that remained in the study long enough to receive multiple immunizations. Three of five multiply immunized dogs also experienced sustained decreases in circulating plasma VEGF concentrations and two dogs had a significant decrease in tumor MVD. The overall tumor response rate was 30% for all treated dogs in the study. We conclude therefore that a xenogeneic VEGF vaccine may be a safe and effective alternative means of controlling tumor growth and angiogenesis.

Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma. Publishing Authors By Initials

D Kamstock,R Elmslie,D Thamm,S Dow,

For similar peptides: intercellular signaling peptides and proteins: angiogenic proteins: vascular endothelial growth factors: vascular endothelial growth factor a research abstracts see: peptides: intercellular signaling peptides and proteins: angiogenic proteins: vascular endothelial growth factors: vascular endothelial growth factor a research

PUBMED ID PMID:

MEDLINE DATE:

Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Cancer immunology, immunotherapy : CII

VOLUME: 56

Page Numbers: 1299-309

Journal Abbreviation: Cancer Immunol. Immunother.

ISSN: 0340-7004

DAY: 14

MONTH: 02

YEAR: 2007

Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8605732

Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma. Keywords Mesh Terms:

KEYWORDS: Vascular Endothelial Growth Factor A

MESH TERMS: immunology

Chemical & Substance for Abstract: Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma. Information

Substance Name: Vascular Endothelial Growth Factor A

Registry Number: 0

Grant and Affiliation Information for Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma.

AFFILIATION: Department of Microbiology, Colorado State University, Ft Collins, CO 80523, USA.

Country: Germany

AGENCY: United States NCI

GRANT: CA86224-01

ACRONYM: CA

MEDLINETA: Cancer Immunol Immunother

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma Related Publications

• Action potentials of cerebellar cortex in response to local electrical stimulation.
• Carbon monoxide exposure on denali: comparing the 2004 and 2005 climbing seasons.
• Complementary global maps for orientation coding in upper and lower layers of the monkey's foveal striate cortex.
• Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.
• Corticotropin releasing hormone modulates endotoxin-induced inflammatory cytokine expression in human trophoblast cells.
• Diarrheal disease control studies; conical net for collecting flies.
• Diversification of the Function of Cell-to-Cell Signaling in Regulation of Virulence Within Plant Pathogenic Xanthomonads.
• EXTRINSIC REGULATORY MECHANISMS OF SEIZURE ACTIVITY.
• Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.
• Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma.
• Excitability of skeletal muscle during development, denervation, and tissue culture.
• Foveal tracking cells in the superior temporal sulcus of the macaque monkey.
• Indications for steroid anaesthesia.
• Infants' early ability to segment the conversational speech signal predicts later language development: a retrospective analysis.
• Integrative physiology, functional genomics and the phenotype gap: a guide for comparative physiologists.
• Interspecies signalling via the Stenotrophomonas maltophilia diffusible signal factor influences biofilm formation and polymyxin tolerance in Pseudomonas aeruginosa.
• Intradural chordoma.
• Liposome-nucleic acid immunotherapeutics.
• Mefloquine-induced disruption of calcium homeostasis in Mammalian cells is similar to that induced by ionomycin.
• Neutrophil function in septic dogs.
• Oxidative stress during acute FIV infection in cats.
• Permanent transvenous dual-chamber pacing using the coronary sinus in a patient with a mechanical prosthetic tricuspid valve.
• Stance dependence of automatic postural adjustments in humans.
• Sustained generation of tissue dendritic cells from cats using organ stromal cell cultures.
• The effect of prolonged veno-arterial pumping on the circulation of the dog.
• The establishment clause argument for choice.
• Treatment of cerebral palsy; clinical study in use of d-tubocurarine in peanut oil and myricin.
• Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer.
• Use of radium in treatment of hypertrophic lymphoid tissue in the nasopharynx.
• Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.